Roger Grau
Impact in
-
- Cancer Cells and Metastasis
- CAR-T cell therapy research
-
- Cancer Genomics and Diagnostics
Papers in
-
- Glycosylation and Glycoproteins Research 3
- Advanced biosensing and bioanalysis techniques 1
- Protein purification and stability 1
-
- Monoclonal and Polyclonal Antibodies Research 4
- Radiopharmaceutical Chemistry and Applications 2
- Co-authors
- Christoph A. Klein (1 shared paper)Pablo Emilio Verde (1 shared paper)Uta Reichelt (1 shared paper)Nikolas H. Stoecklein (1 shared paper)Stefan B. Hosch (1 shared paper)Paulus Schurr (1 shared paper)Wolfram Trudo Knoefel (1 shared paper)P. Scheunemann (1 shared paper)
- Journals
- Blood (2 papers)Molecular Immunology (2 papers)Cancer Research (1 paper)Cancer Cell (1 paper)Biochemical Systematics and Ecology (1 paper)
- Partner nations
- SwitzerlandGermanyUnited Kingdom
In The Last Decade
Roger Grau
9 papers receiving 296 citations
Peers
Comparison fields: 5 of 46
- Oncology 167
- Cancer Research 84
- Radiology, Nuclear Medicine and Imaging 84
- Immunology 66
- Genetics 32
Countries citing papers authored by Roger Grau
This map shows the geographic impact of Roger Grau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Grau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Grau more than expected).
Fields of papers citing papers by Roger Grau
This network shows the impact of papers produced by Roger Grau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Grau. The network helps show where Roger Grau may publish in the future.
Co-authors
The 25 scholars most cited alongside Roger Grau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 162 | |
| 2 | 2006 | 44 | |
| 3 | 2014 | 43 | |
| 4 | 2011 | 30 | |
| 5 | 2005 | 11 | |
| 6 | 1997 | 6 | |
| 7 | 2005 | 4 | |
| 8 | GA201, a novel humanized, glycoengineered EGFR antibody with enhanced ADCC and superior in vivo efficacy in xenograft models | 2008 | 3 |
| 9 | 2008 | 2 |
About Roger Grau
Roger Grau is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Oncology, Genetics and Surgery, having authored 9 papers that have together received 305 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Advanced biosensing and bioanalysis techniques (1 paper), Cancer Treatment and Pharmacology (1 paper), Mesenchymal stem cell research (1 paper), Genetic diversity and population structure (1 paper) and Protein purification and stability (1 paper). The work is most often cited by research in Oncology (167 citations), Cancer Research (84 citations), Radiology, Nuclear Medicine and Imaging (84 citations), Immunology (66 citations) and Genetics (32 citations). Roger Grau has collaborated with scholars based in Switzerland, Germany and United Kingdom. Frequent co-authors include Christoph A. Klein, Pablo Emilio Verde, Uta Reichelt, Nikolas H. Stoecklein, Stefan B. Hosch, Paulus Schurr, Wolfram Trudo Knoefel, P. Scheunemann, Claudia Hartmann and Jakob R. Izbicki. Their work appears in journals such as Blood, Molecular Immunology, Cancer Research, Cancer Cell and Biochemical Systematics and Ecology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.